WHO Chief Tedros Says Received First Expression Of Interest For Emergency Use Listing From Mpox Diagnostics Manufacturer; WHO Officials Discuss Polio Vaccination Plan In Gaza, Confirm Applications From Bavarian Nordic And KM Biologics For Mpox...

世衛組織總幹事譚德塞表示，接到了來自Mpox診斷製造商的首個緊急使用上市的興趣表達；世衛組織官員討論加沙的脊髓灰質炎疫苗接種計劃，並確認了Bavarian Nordic和Km Biologics申請使用Mpox的疫苗急需上市，並宣佈剛果擁有23萬劑可用。

Benzinga · 08/30 21:55

WHO Chief Tedros Says Received First Expression Of Interest For Emergency Use Listing From Mpox Diagnostics Manufacturer; WHO Officials Discuss Polio Vaccination Plan In Gaza, Confirm Applications From Bavarian Nordic And KM Biologics For Mpox Vaccines Emergency Use Listing, And Announce 230,000 Doses Available For Congo

世衛組織總幹事譚德塞表示，接到了來自Mpox診斷製造商的首個緊急使用上市的興趣表達；世衛組織官員討論加沙的脊髓灰質炎疫苗接種計劃，並確認了Bavarian Nordic和Km Biologics申請使用Mpox的疫苗急需上市，並宣佈剛果擁有23萬劑可用。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。